What's Happening?
UPSIDE Foods has announced the launch of a new generation of cultivated chicken products in California foodservice outlets, following a significant expansion of its manufacturing capabilities. The company has increased its production capacity to over
one million pounds of cultivated chicken annually at its Emeryville, California facility, utilizing multiple 20,000-liter bioreactors. This new product combines cultivated chicken cells with plant-based ingredients such as soy protein isolate, pea fiber, and olive oil, and will be available in shredded, diced, and 'chef's cut' formats. UPSIDE Foods has secured its second FDA No Questions Letter and second USDA label approval, making it the first company globally to receive U.S. regulatory clearance for two distinct cultivated meat products. The company aims to make its products competitive with premium chicken prices and is preparing for a new funding round to finance a larger production facility, potentially including the former Believer Meats facility in North Carolina.
Why It's Important?
This development is significant for the cultivated meat industry, which has faced challenges with funding and scalability. UPSIDE Foods' successful scale-up and regulatory approvals could restore confidence in the sector, demonstrating a clearer path to commercial viability and larger-scale production. The hybrid approach, combining cultivated cells with plant-based ingredients, addresses cost and functionality concerns, making the product more accessible and competitive. This move could accelerate the adoption of cultivated meat in the U.S. food supply, offering an alternative protein source that addresses animal welfare, sustainability, and food safety concerns. The ability to produce over one million pounds annually marks a substantial step towards making cultivated meat a more mainstream option, potentially impacting traditional meat markets and driving further innovation in cellular agriculture.
What's Next?
UPSIDE Foods plans to launch a new funding round to finance the construction of a larger production facility, which could further increase its manufacturing capacity. The company is actively pursuing expansion at multiple locations, including the potential acquisition of the Believer Meats facility in North Carolina. The new cultivated chicken product is being introduced at corporate and college dining programs, including Stanford Dining, and at restaurants across California, with halal certification already secured. Future developments will likely focus on further optimizing cell lines, reducing media costs, and developing larger bioreactors (50,000-100,000 liters) to achieve price parity with conventional chicken. The company also expects to launch other high-priced species of cultivated meat, aiming for near-conventional parity at launch.
Beyond the Headlines
The launch of UPSIDE Foods' scaled-up cultivated chicken product signifies a potential turning point for the cellular agriculture industry, moving it from a niche concept to a more tangible market presence. This advancement could trigger broader discussions around food security, ethical food production, and environmental sustainability. The hybrid product model, integrating plant-based components, may set a precedent for future cultivated meat offerings, balancing cost-effectiveness with the unique sensory attributes of cultivated cells. Furthermore, the company's success in securing multiple regulatory clearances could streamline the approval process for other cultivated meat companies, fostering innovation and competition. The revenue generation from its cell culture media arm, Lucius Labs, also highlights a diversified business model, leveraging core technology beyond just meat production into human and animal health bioprocessing applications.













